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pen access Abstract Background: We investigated the cytokine response during coronary artery bypass
grafting (CABG) surgery with and without cardiopulmonary bypass (off-pump) and the effect on
patient’s outcome in the early postoperative period.
Methods: Eighteen patients were studied, 9 patients undergoing off-pump surgery (group 1) and 9
patients with CPB (group 2). Demographic and preoperative characteristics were comparable in
both groups. Plasma levels of TNF-a, IL-6, IL-8, IL-10, IL-4, tumour necrosis soluble receptors-
1 (TNFsr-1) and tumour necrosis soluble receptors-2 (TNFsr-2) were measured before skin incision
(T0), before revascularization (T1), after revascularization (T2), 2 h (T3) and 24 (T4) hours after
skin closure. Levels of myocardial enzymes were also measured in the ﬁrst postoperative morning.
Results: Serum levels of TNF-a and IL-8 increased in group 2 at T3 and T4 more than at T0
(p< 0.05). IL-6 increased in both groups with higher levels in group 2 than in group 1 at T3
(773 ± 331 vs 315 ± 189 pg/ml; p< 0.05). IL-10 was higher in group 2 than in group 1 at T2
(115 ± 119 vs 13 ± 4 pg/ml; p< 0.001) and at T3 (212 ± 171 vs 31 ± 29 pg/ml; p< 0.05). Atrtment of Anesthesiology and
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282 S.R. El Azab et al.T3 levels of TNFsr-1 and TNFsr-2 were higher in group 2 than in group 1 (TNFsr-1 4858 ± 1325 vs
2089 ± 584 pg/ml; p< 0.01 and TNFsr-2 4971 ± 63 vs 3801 ± 738 pg/ml; p< 0.05). Production
of IL-4 did not increase in neither group. The length of ICU stay was less in group 1 than in group 2
(52 ± 33 vs 26 ± 11 h; p< 0.05) as well as was the length of hospital stay (7.1 ± 0.4 vs
5.3 ± 0.5 days; p< 0.001).
Conclusion: Off-pump procedure evoked a lower cytokine response than CABG with CPB. This
minimised myocardial damage and shorten the stay in the ICU and the hospital.
ª 2010 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
The use of beating heart coronary artery bypass grafting or
off-pump (OP-CAB) surgery has become more popular and
widely used. One of the chief reasons for contemporary interest
in the OP-CAB is the desire to minimise the inﬂammatory re-
sponse and to avoid the deleterious systemic effects of the
extracorporeal circulation. Despite the theoretical advantage,
however, it has been reported that OP-CAB also elicits marked
systemic inﬂammatory response [1,2], even to a similar degree
as in on-pump coronary artery bypass graft surgery (CABG)
[3–5].
Studies concerning the different inﬂammatory and cytokine
responses between CABG surgery with and without CPB are
also conﬂicting. In two published studies it was found that
the levels of IL-6 were comparable in the two groups [6,7],
while Struber et al. reported lower IL-6 levels in the off-pump
group [8]. Further, Wei et al. [9] and Orhan et al. [10] found
that the TNF-a production did not differ in patients undergo-
ing CABG with or without CPB but other studies revealed that
levels of TNF-a were lower in OP-CAB surgery [11,12]. Most
of the previous studies were concerned mainly with the pro-
inﬂammatory cytokines. To our knowledge there is no study
reporting the inﬂammatory with the anti-inﬂammatory cyto-
kine responses of two groups of patients undergoing multi-
vessel CABG surgery with and without CPB. We designed a
prospective randomised study to investigate plasma levels of
the inﬂammatory cytokines TNF-a, IL-6 and IL-8 and the
anti-inﬂammatory cytokines IL-10, IL-4, TNFsr-1 and
TNFsr-2 response during and after CABG with and without
CPB and the effect on the early postoperative patient’s out-
come and the length of stay in the ICU an the hospital.
2. Patients and methods
Eighteen patients undergoing elective CABG surgery were ran-
domised for this study. The study was approved by the Ethical
Committee of of King Fahd Specialist Hospital – Burraydah
and all patients gave their informed consents. Exclusion crite-
ria were severely impaired left ventricular function (ejection
fraction <40%), pulmonary disease, severe systemic non-car-
diac disease, renal or liver impairment, insulin dependent dia-
betes, recent myocardial infarction (<6 weeks), infectious
disease before operation or patients under corticosteroid or
other immunosupressive treatment. On the morning of the
operation, patients were randomly selected to either group 1
or group 2; group 1 (9 patients) for off-pump CABG and
group 2 (9 patients) for conventional CABG with CPB. Car-
diac medications including beta-adrenergic blocking agents,
calcium-channel blocking agents and nitrates were continued
until the morning of surgery.All patients were premedicated with lorazepam 40 lg kg1
orally the night of the operation and morphine sulphate
70 lg kg1 and scopolamine 8 lg kg1 intramuscularly 1 h be-
fore the operation. Anaesthesia was induced with sufentanil
2 lg kg1 and midazolam 0.15 mg kg1 and maintained with
sufentanil 1.0 lg kg1 h1 and midazolam 0.12 mg kg1 h1.
In the two groups tracheal intubation was facilitated with pan-
curonium bromide 0.1 mg kg1. A bolus dose of sufentanil
0.5 lg kg1 was given before skin incision. No acute normovo-
laemichaemo dilution was allowed, and no corticosteroids
were given before, during or after the operation. Patients were
ventilated with oxygen/air (inspired oxygen fraction = 0.5)
with a tidal volume of 5–7.5 ml kg1 aiming at normocapnia.
After completion of surgery patients were transferred to the
intensive care unit.
2.1. Off-pump technique (group 1)
A standard median sternotomy was performed. A retractor
(CTS/Guidant Cupertino California) was placed and the peri-
cardial edges were lifted. Three to four deep pericardial
sutures were placed on the left sided pericardium posterior
of the phrenic nerve to rotate and displace the heart anteriorly
and to the right. As an additional measurement, when neces-
sary for the haemodynamic status, the patient was tilted to
the right and placed in Trendelenburg position. Traction on
the right sided pericardial edge sutures was regulated accord-
ing to surgical needs. The temperature of the patient was
maintained above 36 C by a warming mattress and by warm-
ing the intravenous ﬂuid administration. The ultima access
platform/stabiliser (CTS/guidant Cupertino California) was
used for presenting and stabilising the coronary arteries. After
dissecting the left internal mammary artery (LIMA) from its
origin to below the bifurcation, the patient was heparinized
with 200 IU kg1 IV as a bolus followed by an infusion of
2000 IU h1 to maintain the activated coagulation time
(ACT) >300 s (Hemochron 801 International Technidyne
Corp; Edison, NJ). Distal anastomoses were performed ﬁrst.
In all cases the LIMA anastomosis to the diagonal branch(s)
and/or left anterior descending (LAD) were routinely per-
formed ﬁrst before the right internal mammary (RIMA) or
vein graft anastomosis to the right coronary artery (RCA),
inferior and posterior arteries. The proximal vein graft anat-
omises were performed using a side-beating clamp while
maintaining the systolic blood pressure <100 mm Hg. The
distal anastomoses were made under local ligation of the
coronary vessel with prolene 5–0, a FloCal shunt was used
for all distal anastomoses. After the last proximal anastomo-
sis the heparin was reversed by protamine sulphate. Inotropic
support with dopamin and/or noradrenaline was used when
indicated.
Table 1 Demographic and preoperative characteristics of
patient groups.
Group 1
(oﬀ-pump)
Group 2
(oﬀ-pump)
Age (years) 62 ± 6 63 ± 7
Height (cm) 175 ± 11 174 ± 8
Weight (kg) 80 ± 12 85 ± 14
Sex (m/f) 6/3 6/3
NYHAa class (II/III/IV) 2/3/4 2/4/3
Smoking (N/Y)b 4/5 6/3
Diabetes (N/Y)b 8/1 7/2
Hypertension (N/Y)b 7/2 7/2
Number of aﬀected vessels 3.2 ± 0.2 2.8 ± 0.7
The data are shown as mean ± SD for the continuous variables
and as numbers for categorical variables. No signiﬁcant differences
between groups.
a NYHA, New York Heart Association.
b N, no; Y, yes.
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Routine median sternotomy was performed and the pericardial
edges were lifted. After dissecting of the LIMA from its origin
to below the bifurcation, the patient was heparinized with a
bolus of 300 IU kg1 IV to achieve an ACT >450 s. Addi-
tional increments of heparin were administered during the pro-
cedure to maintain the ACT >450 s. Cardiopulmonary bypass
was instituted using a Cobe hollow ﬁbre membrane oxygena-
tor. The circuit was primed with 1100 ml (500 ml gelofu-
sine + 500 ml Ringer’s solution + 100 ml mannitol). The
CPB ﬂow was maintained at 2.4 L min1 m2, and mild hypo-
thermia of 32 C was accomplished. Cold cardioplegic solution
was given after cross-clamping for myocardial protection
(800–1000 ml initially and 200–300 ml after every 30 min
through the aortic root and 100 ml after every distal anasto-
mosis through the vein graft). The distal vein graft anastomo-
ses were performed ﬁrst, while the distal LIMA anastomoses to
the diagonal branches and or LAD were performed last. The
proximal vein graft anastomosis was performed under side
clamping of the aorta. After declamping, the heart was deﬁbr-
illated, if needed, then the patient was rewarmed to a rectal
temperature of at least 34 C. After weaning of the CPB and
decanulation the heparin was reversed with protamine sul-
phate. Inotropic support with dopamin and/or noradrenaline
was used during weaning when indicated.
2.3. Cytokine measurements
Blood sampling for determination of TNF-a, IL-6, IL-8, IL-
10, IL-4, TNFsr-1 and TNFsr-2 was performed at the follow-
ing time points; after induction of anaesthesia and before skin
incision (T0), before starting revascularization in group 1 or
before cardiopulmonary bypass in group 2 (T1), at the end
of revascularization in group 1 or at the end of CBP in group
2 (T2), 2 h (T3) and 24 h after skin closure (T4). Samples were
collected in tubes containing lithium heparin (VenoJect, Ter-
umo, Europe NV, Leuven, Belgium). The samples were imme-
diately centrifuged at 1000g, and the plasma was stored at
70 C until assays were performed. Enzyme-linked immuno-
sorbent assays were used to measure IL-10, IL-4, TNFsr-1 and
TNFsr-2 (R&D Systems Inc., Minneapolis, USA). IL-6, IL-8
and TNF-a were also determined by enzyme-linked immuno-
sorbent assays (Immulite, DPC, Los Angeles, USA). All as-
says were performed according to the manufacturers
instructions.
2.4. Postoperative management
All patients followed standard care and processes on the ICU
and postoperative ward until discharge from the hospital. On
arrival to the ICU, haemodynamic and ventilation criteria
were recorded every 15 min before extubation and hourly until
discharge from ICU. Patients were weaned from mechanical
ventilation as soon as they were haemodynamically stable, re-
sponded to verbal stimulation, completely rewarmed and when
blood loss did not exceed 100 ml/h. Postoperative pain man-
agement was achieved with doses of piritramide i.v. boluses
of 5–10 mg. The time to extubation, postoperative ﬂuid and
blood transfusion requirement, the need for inotropic support,
the presence of postoperative complications, the length of stay
in the ICU and the hospital were recorded. On the ﬁrst postop-erative morning myocardial enzymes including, creatine kinase
(CK), creatine kinase MB fraction (CK-MB), lactate dehydro-
genase (LDH), aspartate aminotransferase (AST) were mea-
sured. Patients were discharged from the ICU on the ﬁrst
morning, if they were haemodynamically stable, had normal
blood gases under spontaneous respiration and acceptable
cardiac enzymes. They were discharged home from the hospi-
tal when they were able to perform basic routine tasks
independently.
2.5. Statistical analysis
Calculations were performed on a personal computer using
SPSS version 16.0.
The groups were tested for differences with Student’s t-test
for continuous variables and Fisher’s exact test for catigorical
variables. For comparing cytokine levels between the two
groups at each time point Mann–Whitney U-test was used. Re-
peated measures analysis of variance together with Bonferroni
adjustment was used for multiple within-group comparisons.
In all cases p value less than 0.05 was considered to indicate
statistical signiﬁcance.
3. Results
Demographic data and the preoperative clinical characteristics
were comparable in both patient groups (Table 1). The intra-
operative course was uneventful and the intraoperative charac-
teristics were comparable in both patient groups (Table 2). In
all patients complete revascularization was achieved.
3.1. Cytokine response
Levels of TNF-a and IL-8 (Fig. 1) were usually low at all times
of measurement in group 1 while both cytokines increased at
T2 and remained high at T3 in group 2. Levels of TNF-a were
higher in group 2 than in group 1 at T3 (93 ± 93 vs 12 ± 7 pg/
ml; p< 0.01) and levels of IL-8 were higher in group 2 at T2
(154 ± 256 vs 13 ± 10 pg/ml; p< 0.05) and at T3 (719 ± 842
vs 27 ± 24 pg/ml; p< 0.01). Levels of IL-6 (Fig. 1) increased
in both groups at T2 and peaked at T3, but they were higher in
Table 2 Intra-operative characteristics of patient groups.
Group 1
(oﬀ-pump)
Group 2
(oﬀ-pump)
p Value
Number of grafts 4.2 ± 0.8 4.3 ± 0.9 0.958
Intraoperative blood intake (ml/kg) 2 ± 3 2 ± 3 0.600
Intraoperative ﬂuid intake (ml/kg)* 52 ± 8 73 ± 13 0.002
Total surgical time (min) 229 ± 70 190 ± 53 0.216
CPBa time (min) _ 114 ± 19 _
Aorta cross-clamping time (min) _ 74 ± 13 _
The data are shown as mean ± SD.
a CPB, cardiopulmonary bypass.
* There is difference between groups.
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Figure 1 Data are expressed as mean ± SE. T0 = after induc-
tion of anaesthesia and before skin incision, T1 = before cardio-
pulmonary bypass or before starting revascularization in group 1,
T2 = end of CBP or end of revascularization in group 1, T3 = 2 h
after skin closure, T4 = 24 h after skin closure. *p value < 0.05
between two times in the same group. **p value < 0.05 between
groups.
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Figure 2 Data are expressed as mean ± SE. T0 = after induc-
tion of anaesthesia and before skin incision, T1 = before cardio-
pulmonary bypass or before starting revascularization in group 1,
T2 = end of CBP or end of revascularization in group 1, T3 = 2 h
after skin closure, T4 = 24 h after skin closure. *p value < 0.05
between two times in the same group. **p value < 0.05 between
groups.
284 S.R. El Azab et al.group 2 than in group 1 at T3 (773 ± 330 vs 315 ± 189 pg/ml;
p< 0.01). Production of IL-10 (Fig. 2) was also signiﬁcantlyhigher in group 2 than in group 1 at T2 (115 ± 119 vs
13 ± 4 pg/ml; p< 0.01) and at T3 (212 ± 171 vs
31 ± 29 pg/ml; p< 0.01). At T3 levels of TNFsr-1 and
TNFsr-2 (Fig. 2) were higher in group 2 than in group 1,
regarding to TNFsr-1 (4858 ± 1325 vs 2089 ± 584 pg/ml;
p< 0.01) and TNFsr-2 (4971 ± 63 vs 3801 ± 738 pg/ml;
p< 0.05). Production of IL-4 (Fig. 2) did not increase through
all times of measurement in both groups.
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In the ICU, no death or major complications occurred in both
groups. Three patients in group 2 needed inotropic support ver-
sus 1 patient in group 1 (p> 0.05), atrial ﬁbrillation was re-
corded in one patient in each group, myocardial infarction
was also recorded in one patient in each group. Postoperative
ﬂuids and blood intake were comparable in both groups. The
minimum and the maximum values of mean blood pressure,
heart rate, cardiac index, haemoglobin content and haemato-
crit percent were comparable in both groups. Inspired oxygen
fraction, PEEP level, mean inspiratory pressure and time to
endotracheal extubation were comparable in both groups. On
the ﬁrst postoperative morning, group 2 had higher levels of
CK-MB (53 ± 53 vs 16 ± 13 lg/L; p=<0.05), LDH
(281 ± 84 vs 176 ± 23 U/L; p< 0.01), AST (70 ± 40 vs
38 ± 13 U/L; p< 0.05). They also stayed longer in the ICU
(52 ± 33 vs 26 ± 11 h; p< 0.05) as well as in the hospital
(5 ± 0.5 vs 7 ± 0.4 days; p< 0.001).4. Discussion
Our data revealed that when compared to conventional
CABG, off-pump surgery is associated with reduced cytokine
response. Moreover, the degree of postoperative myocardial
damage seems low and length of stay in the ICU and the hos-
pital was short.
Unlike Wei et al. [9] and Orhan et al. [10], but in agreement
with others [11,12] we found signiﬁcantly lower levels of TNF-
a in the patients of off-pump group. However in a recent study
it was found that levels of TNF-a did not differ between on-
pump and off-pump CABG surgery [13]. TNF-a has an impor-
tant role in myocardial ischaemia–reperfusion injury [14,15]. It
is primarily produced by non-cardiac-activated macrophages
in response to ischaemia and reperfusion [16]. Then the circu-
lating TNF-a stimulates intracellular adhesion molecule-1
(ICAM-1) expression on cardiac myocytes [17], which in turn
promotes adhesive interaction between transmigrated neutro-
phils and cardiac myocytes of the reperfused myocardium
[18]. TNF-a is also known to trigger the release of all known
mediators of inﬂammation including other cytokines and all
metabolites of arachidonic acid. It damages the host by induc-
ing and enhancing the production of reactive oxygen deriva-
tives [19].
We noticed that the production of IL-8 was maintained
low in the off-pump group at all measurements, although
it increased signiﬁcantly in the other group after the end
of CPB to peak 2 h after skin closure. The clinical beneﬁts
of this ﬁnding can be expected because IL-8 is known to
be one of the important mediators in ischaemia–reperfusion
injury through effect on neutrophil activation and its adher-
ence to the vascular endothelium [20]. Furthermore blocking
of the IL-8 response by the administration of anti IL-8 anti-
bodies prevents lung ischaemia–reperfusion injury in rabbits
[21].
We found high levels of IL-6 in both groups, albeit higher
in the CPB group, implying that the production of this cyto-
kine might be inﬂuenced by the degree of surgical trauma
and tissue damage rather than by the effect of CPB itself [7].
It has been suggested that IL-6 may be a more sensitive indica-
tor of the degree of myocardial damage, and an associationwas found between the size of IL-6 response and cardiac
morbidity [22]. High concentrations of IL-6 may impair car-
diac function as a result of negative inotropic effects possibly
due to impaired entry of calcium into myocardial cells [23].
Moreover, IL-6 may have anti-inﬂammatory effects through
direct suppression of TNF as well as through the induction
of natural antagonist of TNF [24].
The causal relationship between pro- and anti-inﬂamma-
tory cytokines was exempliﬁed in our study by the IL-10
response which followed the IL-8 response in both groups.
This ﬁnding was previously reported in the results of Wan et
al. when they found that the levels of IL-10 were proportional
to the levels of IL-8 in patients of CABG surgery with and
without CPB [7]. IL-10 increased only in the CPB group while
it remained low throughout measurements in the off-pump
group. IL-10 is a potent inhibitor of pro-inﬂammatory cyto-
kines, suggesting that it may also have an important regulatory
role in limiting the duration and extent of the acute inﬂamma-
tory response [25].
We found signiﬁcantly raised levels of TNFsr-1 and TNFsr-
2 in group 2. These endogenously released soluble receptors
may compete with the cell-surface receptors for the binding
of TNF, thus acting as physiological inhibitors [26]. In addi-
tion, the shedding of extracellular moiety of TNF receptors
may decrease the sensitivity of these cells to TNF [27]. Whereas
soluble TNF receptors are believed to be reliable markers for
the activity in the TNF system [28], the biologic signiﬁcance
of these receptors is not yet fully understood. However it
was found that high plasma levels of sTNF-RII were signiﬁ-
cantly associated with increased incidence of Coronary Heart
disease [29].
In spite of the limited number of patients enrolled in our
study, we could notice that the clinical outcome was better
in the off-pump group as reﬂected by the lower myocardial en-
zymes and the shorter stay in the ICU and the hospital. The
elevated myocardial enzymes in patients whom have been
operated with CPB may be due to the high levels of pro-inﬂam-
matory cytokines in this group, although these patients were
treated with cold cardioplegia. However the potential involve-
ment of the inﬂammatory cytokines in postoperative myocar-
dial dysfunction was previously supported by Hennein et al.
[20] who found that postoperative left ventricular wall abnor-
malities were associated with high serum levels of IL-6 and IL-
8. We think that prevention or attenuation of the cytokine re-
sponse during off-pump operation should offer a means of
substantially reducing potential morbidity.
In conclusion, this prospective randomised study suggests
that in low-risk patients undergoing elective CABG, off-pump
technique signiﬁcantly reduces the inﬂammatory as well as the
anti-inﬂammatory cytokine responses, decreases postoperative
myocardial damage and shortens the length of stay in the ICU
and the hospital. A larger prospective and randomised study
should conﬁrm the postoperative clinical beneﬁts of the off-
pump technique.References
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